US Patent 7183413 Aminoquinoline compounds
Patent 7183413 was granted and assigned to TaiGen Biotechnology on February, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Chih-Wei Chang0
Chu-Chung Lin0
Jen-Fuh Liu0
Jiing-Jyh Jan0
Pei-Chin Cheng0
Shu-Jen Chen0
Yibin Xiang0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+270 characters)
Article
Patent abstract
This invention relates to treating inflammatory and immune diseases with certain aminoquinoline compounds that bind to CXCR3 receptors. The aminoquinoline compounds are covered by the formula (I) shown below. Each variable is defined in the specification.
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07183413 Aminoquinoline compounds US Patent 7183413 Aminoquinoline compounds
Infobox
Patent Number
071834130
Patent Number
71834130
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071834130
Date of Patent
February 27, 2007
0Patent Application Number
108196460
Date Filed
April 6, 2004
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07183413 Aminoquinoline compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07183413
Date of patent
February 27, 2007
Patent application number
10819646
Date Filed
April 6, 2004
Patent primary examiner
Find more entities like US Patent 7183413 Aminoquinoline compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
